Cytokinetics公司CEO罗伯特·I·布卢姆披露普通股出售计划

华尔街洞察
Jul 16, 2025

近日,Cytokinetics Incorporated的总裁兼首席执行官罗伯特·I·布卢姆正式宣布,已处置了该公司的普通股。这一举动突显了高管层的股权变动细节。完整的申报文件可通过下方链接查阅,便于投资者深入了解相关交易内容。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10